Govt Job for M.Pharm, M.Sc at Department of Atomic Energy

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state of art of R&D wing of the Tata Memorial Centre.

It is located in the picturesque settings at the foot hills of the Sahyadri mountains in Kharghar, Navi Mumbai.

ACTREC comprises of, the Cancer Research Institute (CRI), Clinical Research Centre (CRC) and Centre for Cancer Epidemiology (CEC), a setting that is unique in India and built and evolved with a vision to provide comprehensive cancer care to one and all, through its motto of excellence in services, education and research.

Post : JUNIOR RESEARCH FELLOW (1 Post)

TATA MEMORIAL CENTRE, A Grant-in-aid Institution of the Dept. of Atomic Energy, Government of India

Minimum Qualification : M.Sc. (Life science)/ M.Pharm (Pharmacology) or equivalent with minimum 60% in the qualifying exam.
*M.Sc. degree having duration of one year course will not be considered.

Consolidated Salary : Rs. 38,440/- p.m. (Rs. 31,000/-+24%HRA).
Duration : Six months.

Eligible Candidates may attend the walk in interview on 25th May,2021(Tuesday) at KS-Meeting Room, 3rd Floor, Khanolkar Shodhika, ACTREC along with recent CV, original and attested copies of all certificates and testimonials with recent passport size photograph. Reporting Time: 09:30 a.m. to 10:30 a.m.

Ask PI following things in the same mail:
1. Interview date
2. Committee members
3. Probable joining date of selected candidates.

TATA MEMORIAL CENTRE
ADVANCED CENTRE FOR TREATMENT, RESEARCH AND EDUCATION IN CANCER
Kharghar, Navi Mumbai-410 210

Related Posts

Trump’s tariffs on India: What forced the US govt to leave Indian pharma out of the 50% tax bracket?

The Indian pharmaceutical industry has been exempted from immediate tariff increases in the US due to the significance of generic medications for providing affordable healthcare in the country. This decision…

GSK Pharma forays into gynaecological cancer treatment in India

GlaxoSmithKline Pharmaceuticals Ltd. stock zoomed as much as 2% on Monday, August 25. This movement in shares came after the company announced its entry into the oncology segment in India…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump’s tariffs on India: What forced the US govt to leave Indian pharma out of the 50% tax bracket?

Trump’s tariffs on India: What forced the US govt to leave Indian pharma out of the 50% tax bracket?

Fake medicines worth Rs 2.13 crore recovered from Himanshu Agarwal’s warehouse, case registered

Fake medicines worth Rs 2.13 crore recovered from Himanshu Agarwal’s warehouse, case registered

UNESCO Chair on Global Health backs PM Modi’s Call on Obesity

UNESCO Chair on Global Health backs PM Modi’s Call on Obesity

Lucknow bribery case: CBI arrests two narcotics inspectors, nursing home owner

Lucknow bribery case: CBI arrests two narcotics inspectors, nursing home owner